Skip to Content
  • Tracked for
    Impact Factor
  • 2.4
    CiteScore
  • 40 days
    Time to First Decision

Endocrines, Volume 3, Issue 3

2022 September - 20 articles

Cover Story: After the identification of fibroblast growth factor (FGF) 23 as the causative molecule for the development of chronic hypophosphatemia, a lot of progress has been achieved in the diagnosis and treatment of X-linked hypophosphatemia (XLH), including the development of a game-changing anti-FGF23 antibody: burosumab. In the future, typical phenotypes of hypophosphatemic rickets/osteomalacia will be significantly alleviated with the new drug. XLH and other FGF23-related hypophosphatemia present specific phenotypes of unknown etiology, including early-onset osteoarthritis and enthesopathy, which significantly debilitate the quality of life (QOL) with pain, neural symptoms, and impingement syndrome in some patients with XLH. To genuinely improve the QOL of all XLH patients, clarification of the mechanism for the development of these specific complications in XLH is urgently needed. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (20)

  • Article
  • Open Access
2,656 Views
8 Pages

Serum IL-1ra Is Associated with but Has No Genetic Link to Type 1 Diabetes

  • Paul M. H. Tran,
  • Fran Dong,
  • Khaled Bin Satter,
  • Katherine P. Richardson,
  • Roshni Patel,
  • Lynn K. H. Tran,
  • Diane Hopkins,
  • Ravindra Kolhe,
  • Kathleen Waugh and
  • Sharad Purohit
  • + 1 author

13 September 2022

Interleukin-1 antagonism is a proposed biomarker and potential therapy for the delay and/or treatment of type 1 diabetes (T1D). We evaluated the role of circulating interleukin-1 receptor antagonist (IL-1ra) in a prospectively monitored cohort of T1D...

  • Review
  • Open Access
4 Citations
3,828 Views
10 Pages

Complications and Treatments in Adult X-Linked Hypophosphatemia

  • Yasuo Imanishi,
  • Tetsuo Shoji and
  • Masanori Emoto

8 September 2022

X-linked hypophosphatemia (XLH) is a rare inherited disorder involving elevated levels of fibroblast growth factor (FGF) 23, and is caused by loss-of-function mutations in the PHEX gene. FGF23 induces renal phosphate wasting and suppresses the activa...

  • Review
  • Open Access
4 Citations
4,341 Views
8 Pages

The Possible Role of SARS-CoV-2 in Male Fertility: A Narrative Review

  • Claudia Leanza,
  • Laura M. Mongioì,
  • Rossella Cannarella,
  • Sandro La Vignera,
  • Rosita A. Condorelli and
  • Aldo E. Calogero

5 September 2022

The spread of severe acute respiratory syndrome—Coronavirus 2 (SARS-CoV-2) around the world has rapidly sparked the interest of the scientific community to discover its implications in human health. Many studies have suggested that SARS-CoV-2 i...

  • Communication
  • Open Access
8 Citations
5,612 Views
7 Pages

1 September 2022

Prediabetes, the precursor of type 2 diabetes (T2D), is on the rise among children and adolescents in the United States. The natural history of prediabetes is poorly characterized in children compared to adults. The available data indicate a phenotyp...

  • Feature Paper
  • Article
  • Open Access
4 Citations
13,337 Views
7 Pages

Effects of One-Shot Hyaluronic Acid Injection in Lifelong Premature Ejaculation: A Pilot Study

  • Anna Perri,
  • Danilo Lofaro,
  • Stefano Iuliano,
  • Sabrina Bossio,
  • Vittoria Rago,
  • Rocco Damiano,
  • Luigi Di Luigi,
  • Sandro La Vignera,
  • Nicola Mondaini and
  • Antonio Aversa

1 September 2022

The therapeutic management of premature lifelong ejaculation (PE) ranges from behavioral therapy to pharmacological and surgical treatments. Hyaluronic Acid (HA) injection into the glans penis is a non-surgical procedure, intended to reduce glans hyp...

  • Article
  • Open Access
5 Citations
7,500 Views
8 Pages

16 August 2022

Impacts of subclinical reactive hypoglycemia on food ingestion are not well studied. In the present study, in obese/overweight males without diabetes (n = 34), continuous glucose monitoring and eating behavior were recorded for 6 days after the 75 g...

  • Feature Paper
  • Review
  • Open Access
2 Citations
5,751 Views
8 Pages

Treatment of X-Linked Hypophosphatemia in Children

  • Toshihiro Tajima and
  • Yukihiro Hasegawa

11 August 2022

The conventional treatment for X-linked hypophosphatemia (XLH), consisting of phosphorus supplementation and a biologically active form of vitamin D (alfacalcidol or calcitriol), is used to treat rickets and leg deformities and promote growth. Howeve...

  • Article
  • Open Access
6 Citations
4,609 Views
10 Pages

The Initial ATA Risk Classification, but Not the AJCC/TNM Stage, Predicts the Persistence or Relapse of Differentiated Thyroid Cancer in Long-Term Surveillance

  • Stefania Giuliano,
  • Maria Mirabelli,
  • Eusebio Chiefari,
  • Vera Tocci,
  • Alessandra Donnici,
  • Stefano Iuliano,
  • Alessandro Salatino,
  • Daniela Patrizia Foti,
  • Antonio Aversa and
  • Antonio Brunetti

10 August 2022

Background: The American Joint Commission on Cancer on Tumor Node Metastasis (AJCC/TNM) staging system provides adequate information on the risk of differentiated thyroid cancer (DTC)-specific mortality in totally thyroidectomized patients, but its r...

  • Feature Paper
  • Review
  • Open Access
5 Citations
4,524 Views
14 Pages

Pathogenic Variants of the PHEX Gene

  • Yasuhisa Ohata and
  • Yasuki Ishihara

8 August 2022

Twenty-five years ago, a pathogenic variant of the phosphate-regulating endopeptidase homolog X-linked (PHEX) gene was identified as the cause of X-linked hypophosphatemic rickets (XLH). Subsequently, the overproduction of fibroblast growth factor 23...

  • Review
  • Open Access
5 Citations
3,909 Views
10 Pages

3 August 2022

X-linked hypophosphatemia is an inheritable disease of renal phosphate wasting that results in clinically manifestations associated with rickets or osteomalacia. The various symptoms in the skeletal system are well recognized, such as short stature;...

  • Review
  • Open Access
3 Citations
2,925 Views
12 Pages

2 August 2022

Turner syndrome (TS) is a chromosomal disorder characterized by a short stature and gonadal dysgenesis, the latter of which requires estrogen replacement therapy (ERT) to induce and maintain secondary sexual characteristics. Insufficient ERT is assoc...

  • Feature Paper
  • Article
  • Open Access
2 Citations
3,284 Views
16 Pages

28 July 2022

Leydig cells produce androgens which are essential for male sex differentiation and reproductive functions. Steroidogenesis, as well as expression of several genes in Leydig cells, are stimulated by LH/cAMP and repressed by AMP/AMPK. One of those gen...

  • Review
  • Open Access
4 Citations
3,664 Views
8 Pages

26 July 2022

Burn injury serves as an example of a condition with a robust systemic inflammatory response. The elevation of circulating interleukins (IL)-1β and -6 in children and adolescents with severe burn injury upregulates the parathyroid calcium-sensing rec...

  • Review
  • Open Access
6 Citations
6,816 Views
19 Pages

25 July 2022

Despite the growing prevalence of central precocious puberty (CPP), most cases are still diagnosed as “idiopathic” due to the lack of identifiable findings of other diagnostic etiology. We are gaining greater insight into some key genes a...

  • Article
  • Open Access
3,550 Views
5 Pages

Molecular Basis for Hypochondroplasia in Japan

  • Tomohiro Ishii,
  • Masaki Takagi,
  • Keisuke Nagasaki,
  • Toshio Ohara,
  • Kentaro Miyai,
  • Tomoki Kosho,
  • Fumio Takada,
  • Gen Nishimura and
  • Tomonobu Hasegawa

22 July 2022

Hypochondroplasia is an autosomal dominant genetic disorder due to a heterozygous pathogenic variant of the FGFR3 gene. The early diagnosis of hypochondroplasia is necessary, since growth hormone is effective for improving adult height. The genetic t...

  • Review
  • Open Access
4 Citations
10,833 Views
9 Pages

6 July 2022

Human growth hormone (hGH) has been used therapeutically to promote growth in children for over 60 years. Pituitary-extracted hGH has demonstrated positive growth promotion since the early 1960s. In 1985, prion-induced contamination of hGH triggered...

  • Review
  • Open Access
5 Citations
3,564 Views
8 Pages

5 July 2022

X-linked hypophosphatemia (XLH) is the most common form of inherited disorders that are characterized by renal phosphate wasting, but it is a rare chronic disease. XLH presents in multisystemic organs, not only in childhood, but also in adulthood. Mu...

  • Review
  • Open Access
19 Citations
22,739 Views
20 Pages

The Old and the New in Subacute Thyroiditis: An Integrative Review

  • Nicola Lanzo,
  • Bohdan Patera,
  • Gaia Francesca Maria Fazzino,
  • Daniela Gallo,
  • Adriana Lai,
  • Eliana Piantanida,
  • Silvia Ippolito and
  • Maria Laura Tanda

4 July 2022

Subacute thyroiditis (SAT) is the most common cause of neck pain and thyrotoxicosis. Although this disease was recognized already by the end of the 18th century, new concepts regarding pathogenesis have emerged in recent years. Moreover, in the last...

  • Review
  • Open Access
7 Citations
5,714 Views
8 Pages

Kisspeptin Modulation of Reproductive Function

  • Anna Szeliga and
  • Blazej Meczekalski

30 June 2022

Kisspeptin is a peptide expressed mainly in the infundibular nucleus of the hypothalamus. Kisspeptin plays a crucial role in the regulation of reproductive functions. It is regarded as the most important factor responsible for the control of the hypo...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Endocrines - ISSN 2673-396X